Claybrook Capital’s Medtronic MDT Stock Holding History

Claybrook Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,042	Closed	-$502K	–	195
2021 Q2	$502K	Buy	+4,042	New	+$508K	0.16%	106
2020 Q4	–	Sell	-5,600	Closed	-$582K	–	97
2020 Q3	$582K	Buy	5,600 +600	+12%	+$60.3K	0.44%	50
2020 Q2	$459K	Buy	+5,000	New	+$479K	0.39%	53
2019 Q1	–	Sell	-25	Closed	-$2K	–	446
2018 Q4	$2K	Buy	+25	New	+$2.34K	﹤0.01%	642

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Claybrook Capital's MDT Position: Q3 2021 in Review

Claybrook Capital sold out of Medtronic (MDT) in Q3 2021, closing a stake of 4,042 shares — an estimated $502K sold.

Claybrook Capital first reported a position in MDT in Q4 2018 and held it in 4 quarters. The position peaked at $582K in Q3 2020. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

Claybrook Capital reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
Claybrook Capital sold 4,042 Medtronic shares in Q3 2021, an estimated $502K.
Claybrook Capital first reported a position in Medtronic in Q4 2018 and held it in 4 quarters.
Claybrook Capital's Medtronic position peaked at $582K in Q3 2020.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Claybrook Capital's 13F filing for Q3 2021, filed 15 Nov 2021.